Potential of limited day 21 post-chemotherapy CT scan in predicting need for post-chemotherapy surgery in nonseminomatous testicular germ cell cancer

Urologia Internationalis

Volumn 61, Issue 1, 1998, Pages 22-26

  Tsetis, Dimitrios ^a   Sharma, Amita ^a   Easty, Marina ^a   Brown, Ivan ^a   Oliver, Tim ^a   Chan, Otto ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

CT scan; Prognosis; Testicular neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; HUMAN; MALE; NON SEMINOMATOUS GERMINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; STEM CELL; TESTIS TUMOR; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031737194     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030278     Document Type: Article

References (17)

1. Einhorn LH: Treatment of testicular cancer: A new and improved model. J Clin Oncol 1990;8:1777.
2. Oliver RT, Ong J, Blandy JP, Altman DG: Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978-1994. Br J Urol 1996;78:119-124.
3. Freedman L, Oliver R, Peckham M: Prognostic factors in advanced nonseminomatous germ cell testicular tumours: Results of a multicentre study. Lancet 1985;i:8-11.
4. Mead G, Stenning S, Cook P, et al: International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
5. Einhorn LH, Williams SD, Loehrer PJ, et al: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group Protocol. J Clin Oncol 1989;7:387-391.
6. Donohue JP, Rowland RG: The role of surgery in advanced testicular cancer. Cancer 1984;54(suppl 11):2716-2721.
7. Boshoff CB, Begent RHJ, Oliver RTD, et al: Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 1995;6:35-40.
8. Oliver RTD, Dhaliwal HS, Hope-Stone HF, Blandy JP. Short course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumours. Br J Urol 1988;61:53-58.
9. Carey BM, Robinson PJ, Jones WG: Computed tomographic appearances of treated metastatic testicular tumours. Clin Radiol 1989;40:406-412.
10. Husband JE, Hawkes DJ, Peckham MJ: CT estimations of mean attenuation values and volume in testicular tumors: A comparison with surgical and histologic findings. Radiology 1982;144:553-558.
11. Husband JE, Peckham MJ, Macdonald JS: The role of abdominal computed tomography in the management of testicular tumours. Comput Tomogr 1980;4:1-16.
12. Lien HH, Stenwig AE, Ous S, Fossa SD: Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with nonseminomatous testicular tumour. Acta Radiol 1986;27:199.
13. MacVicar D: Staging of testicular germ cell tumours. Clin Radiol 1993;47:149-158.
14. Donohue JP, Rowland RG, Kopecky K, et al: Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 1987;137:1176-1179.
15. Scatarige JC, Fishman EK, Kuhajda FP, Taylor GA, Siegelman SS: Low attenuation nodal metastases in testicular carcinoma. J Comput Assist Tomogr 1983;7:682-687.
16. Steinfeld AD: Testicular germ cell tumors: Review of contemporary evaluation and management. Radiology 1990;175:603-606.
17. Stomper OC, Fung CY, Socinski MA, et al: Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer. Analysis of different criteria. Am J Roentgenol 1987,149:1187.